Management of Urinary Tract Infections from Multidrug-Resistant Organisms

被引：79

作者：

Gupta, Kalpana ^{[1
,2
]}

Bhadelia, Nahid ^{[3
]}

机构：

[1] VA Boston HCS, Roxbury, MA 02132 USA

[2] Boston Univ, Sch Med, Boston, MA 02115 USA

[3] Boston Univ, Sch Med, Boston Med Ctr, Infect Dis Sect, Boston, MA 02115 USA

来源：

INFECTIOUS DISEASE CLINICS OF NORTH AMERICA | 2014年 / 28卷 / 01期

关键词：

Multidrug-resistant organisms; Cystitis; Extended-spectrum beta-lactamases; Carbapenem-resistant Enterobacteriaceae; Vancomycin-resistant Enterococcus; SPECTRUM BETA-LACTAMASES; IN-VITRO ACTIVITY; ACUTE UNCOMPLICATED CYSTITIS; ESCHERICHIA-COLI; KLEBSIELLA-PNEUMONIAE; ANTIMICROBIAL RESISTANCE; MOLECULAR EPIDEMIOLOGY; STAPHYLOCOCCUS-AUREUS; ACUTE PYELONEPHRITIS; RECURRENT UROSEPSIS;

D O I：

10.1016/j.idc.2013.10.002

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Antibiotic resistance worsens clinical outcomes and, in some cases, significantly impacts the clinical management of urinary tract infections in the outpatient setting. This article presents the prevalence and mechanism of relevant antimicrobial resistance patterns encountered among uropathogens, and discusses the efficacy of antibiotic regimens and novel therapies in treating commonly encountered multidrug-resistant organisms.

引用

页码：49 / +

页数：12

共 60 条

[1]

[Anonymous], 2010, PRINCIPLES PRACTICE

[2] Oral Treatment Options for Ambulatory Patients with Urinary Tract Infections Caused by Extended-Spectrum-β-Lactamase-Producing Escherichia coli [J].

Auer, Simon ;

Wojna, Alexandra ;

Hell, Markus .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (09) :4006-4008

[3] Predictive value of Escherichia coli susceptibility in strains causing asymptomatic bacteriuria for women with recurrent symptomatic urinary tract infections receiving prophylaxis [J].

Beerepoot, M. A. J. ;

den Heijer, C. D. J. ;

Penders, J. ;

Prins, J. M. ;

Stobberingh, E. E. ;

Geerlings, S. E. .

CLINICAL MICROBIOLOGY AND INFECTION, 2012, 18 (04) :E84-E90

[4] 10 x '20 Progress-Development of New Drugs Active Against Gram-Negative Bacilli: An Update From the Infectious Diseases Society of America [J].

Boucher, Helen W. ;

Talbot, George H. ;

Benjamin, Daniel K., Jr. ;

Bradley, John ;

Guidos, Robert J. ;

Jones, Ronald N. ;

Murray, Barbara E. ;

Bonomo, Robert A. ;

Gilbert, David .

CLINICAL INFECTIOUS DISEASES, 2013, 56 (12) :1685-1694

[5] New antimicrobial agents on the horizon [J].

Bush, Karen ;

Pucci, Michael J. .

BIOCHEMICAL PHARMACOLOGY, 2011, 82 (11) :1528-1539

[6] Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum β-lactamases [J].

Calbo, E ;

Romaní, V ;

Xercavins, M ;

Gómez, L ;

Vidal, CG ;

Quintana, S ;

Vila, J ;

Garau, J .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 57 (04) :780-783

[7] Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene [J].

Chang, S ;

Sievert, DM ;

Hageman, JC ;

Boulton, ML ;

Tenover, FC ;

Downes, FP ;

Shah, S ;

Rudrik, JT ;

Pupp, GR ;

Brown, WJ ;

Cardo, D ;

Fridkin, SK .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (14) :1342-1347

[8] The relationship between antimicrobial resistance and patient outcomes: Mortality, length of hospital stay, and health care costs [J].

Cosgrove, SE .

CLINICAL INFECTIOUS DISEASES, 2006, 42 :S82-S89

[9] Health and economic outcomes of the emergence of third-generation cephalosporin resistance in Enterobacter species [J].

Cosgrove, SE ;

Kaye, KS ;

Eliopoulous, GM ;

Carmeli, Y .

ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (02) :185-190

[10] Treatment of recurrent urosepsis with tigecycline: a pharmacological perspective [J].

Curcio, Daniel .

JOURNAL OF CLINICAL MICROBIOLOGY, 2008, 46 (05) :1892-1893

← 1 2 3 4 5 6 →